27EC Yeo, Charles - Thomas Jefferson University - Thomas Jefferson University
Charles J. Yeo, MD, FACS

Charles J. Yeo, MD, FACS

Contact Dr. Yeo

1015 Walnut Street
Curtis Building, Suite 620
Philadelphia, PA 19107

(215) 955-8643
(215) 923-6609 fax

Most Recent Peer-reviewed Publications

  1. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: A consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)
  2. Non-neoplastic Epithelial Cysts of the Pancreas: A Rare, Benign Entity
  3. Complex cystic lesions in the liver causing abdominal pain
  4. HuR posttranscriptionally regulates WEE1: Implications for the DNA damage response in pancreatic cancer cells
  5. Overexpressing TNF-Alpha in Pancreatic Ductal Adenocarcinoma Cells and Fibroblasts Modifies Cell Survival and Reduces Fatty Acid Synthesis via Downregulation of Sterol Regulatory Element Binding Protein-1 and Activation of Acetyl CoA Carboxylase
  6. Does Resident Experience Affect Outcomes in Complex Abdominal Surgery? Pancreaticoduodenectomy as an Example
  7. Roscoe Reid Graham (1890 to 1948): a Canadian pioneer in general surgery.
  8. Grit: A marker of residents at risk for attrition?
  9. Intraoperative Pancreatoscopy: A Valuable Tool for Pancreatic Surgeons?
  10. Safety of perioperative aspirin therapy in pancreatic operations
  11. When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery
  12. The HYSLAR trial: A prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated ringers in patients undergoing pancreaticoduodenectomy
  13. Emergent pancreaticoduodenectomy: A dual institution experience and review of the literature
  14. Extended pancreatectomy in pancreatic ductal adenocarcinoma: Definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS)
  15. Clinical Significance of Serum COL6A3 in Pancreatic Ductal Adenocarcinoma
  16. Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
  17. Dr. Seishu Hanaoka (1760-1835): surgeon, pharmacist, and anesthesiologist.
  18. Targeting PARP-1 allosteric regulation offers therapeutic potential against cancer
  19. Mary H. Gibbon: teamwork of the heart.
  20. dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer: A dual-institutional follow-up with the RTOG 9704 trial
0